<DOC>
	<DOCNO>NCT02840669</DOCNO>
	<brief_summary>Friedreich 's ataxia ( FA ) autosomal recessive disease incidence 1/50,000 Caucasian population . The main manifestation FA progressive sensory cerebellar ataxia cardiomyopathy ( CM ) . It common form inherit ataxia . A severe CM affect ~60 % FA patient , mostly young adult , lead cardiac failure death . Currently , therapy change course severe cardiomyopathy . This study design characterize cardiac manifestation FA use cardiac magnetic resonance ( CMR ) , echocardiography , serum cardiac biomarkers evaluation fatigue severity , context neurological disease .</brief_summary>
	<brief_title>A Study Characterize Cardiac Phenotype Individuals With Friedreich 's Ataxia ( CARFA Study )</brief_title>
	<detailed_description />
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<mesh_term>Friedreich Ataxia</mesh_term>
	<criteria>Inclusion Criteria ( Friedreich 's Ataxia ) : Males female ; ≥ 18 year old ; Willing able provide inform consent ; Definitive diagnosis FA , base clinical phenotype genotype ; With hypertrophic cardiomyopathy ; Ability complete study assessment . Exclusion Criteria ( Friedreich 's Ataxia ) : Symptoms cardiac failure ; Moderate severe atrial ventricular arrhythmia ; History angina pectoris ; Inability undergo cardiac MRI ; Clinical history evidence diabetes ; Abnormal kidney function ; Females pregnant nursing ; Receipt investigational drug within 30 day 5 halflives , active enrollment investigational medication device study ; Inability sit back support ; Inability undergo exercise test ; Inability comply study requirement ; Unaffiliated French health insurance equivalent . Inclusion Criteria ( Healthy Volunteers ) : Healthy male female ; ≥ 18 year old ; Willing able provide inform consent ; Age gender match Friedreich 's Ataxia group ; Ability complete study assessment . Exclusion Criteria ( Healthy Volunteers ) : Inability undergo cardiac MRI ; Clinical history evidence diabetes ; Abnormal kidney function ; Females pregnant nursing ; Receipt investigational drug within 30 day 5 halflives , active enrollment investigational medication device study ; Inability undergo exercise test ; Inability comply study requirement ; Unaffiliated French health insurance equivalent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cardiomyopathy</keyword>
</DOC>